Search for diabetic nephropathy genes: New directions;Poszukiwanie genów dla nefropatii cukrzycowej: Nowe kierunki

Przeglad Pediatryczny

Volumn 33, Issue 2, 2003, Pages 97-104

  Młynarski, Wojciech ^a   Wołkow, Paweł P ^a   Krolewski, Andrzej S ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Genetics; Nephropathy; Type 1 diabetes

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

DIABETIC NEPHROPATHY; DNA MICROARRAY; FAMILIAL DISEASE; GENE CLUSTER; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; GENOME; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DYSFUNCTION; PROTEINURIA; REVIEW;

EID: 0038801735     PISSN: 0137723X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA 2002, 287, 2563-2569.
2. Dahlquist G., Rudberg S. The prevalence of microalbuminuria in diabetic children and adolescents and its relation to puberty. Acta Paediatr. Scand. 1987, 76, 795-800.
3. Andersen A. R., Christiansen J. S., Andersen J. K., Kreiner S., Deckert T. Diabetic nephropathy in Type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia 1983, 25, 496-501.
4. Krolewski A. S., Warram J. H., Christlieb A. R., Busick E. J., Kahn C. R. The changing natural history of nephropathy in type I diabetes. Am. J. Med. 1985, 78, 785-794.
5. Seaquist E. R., Goetz F. C., Rich S., Barbosa J. Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. N. Engl. J. Med. 1989, 320, 1161-1165.
6. Borch-Johnsen K., Norgaard K., Hommel E., Mathiesen E. R., Jensen J. S., Deckert T., Parving H. H. Is diabetic nephropathy an inherited complication? Kidney Int. 1992, 41, 719-722.
7. Quinn M., Angelico M. C., Warram J. H., Krolewski A. S. Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia 1996, 39, 940-945.
8. Rogus J. J., Krolewski A. S. Using discordant sib pairs to map loci for qualitative traits with high sibling recurrence risk. Am. J. Hum. Genet. 1996, 59, 1376-1381.
9. Clustering of long-term complications in families with diabetes in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group. Diabetes 1997, 46, 1829-1839.
10. Khoury M. J., Flanders W. D., Greenland S., Adams M. J. On the measurement of susceptibility in epidemiologic studies. Am. J. Epidemiol. 1989, 129, 183-190.
11. Hopper J. L., Carlin J. B. Familial aggregation of a disease consequent upon correlation between relatives in a risk factor measured on a continuous scale. Am. J. Epidemiol. 1992, 136, 1138-1147.
12. Spielman R. S., McGinnis R. E., Ewens W. J. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am. J. Hum. Genet. 1993, 52, 506-516.
13. Imperatore G., Hanson R. L., Pettitt D. J., Kobes S., Bennett P. H., Knowler W. C. Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes. Pima Diabetes Genes Group. Diabetes 1998, 47, 821-830.
14. Moczulski D. K., Rogus J. J., Antonellis A., Warram J. H., Krolewski A. S. Major susceptibility locus for nephropathy in type 1 diabetes on chromosome 3q: results of novel discordant sib-pair analysis. Diabetes 1998, 47, 1164-1169.
15. Antonellis A., Rogus J. J., Canani L. H., Makita Y., Pezzolesi M.G., Nam M., Ng D., Moczulski D., Warram J. H., Krolewski A. S. A method for developing high-density SNP maps and its application at the type 1 angiotensin II receptor (AGTR1) locus. Genomics 2002, 79, 326-332.
16. Osterholm A. M., He B., Pitkaniemi J., Reynisdottir I., Berg T., Tuomilehto J., Tryggvason K. An initial genome scan for type 1 diabetec nephropathy susceptibility loci in the Finnish population. Am. J. Hum. Genet. 2002, 71, 453.
17. Cheng J., Grande J. P. Transforming growth factor-beta signal transduction and progressive renal disease. Exp. Biol. Med. (Maywood.) 2002, 227, 943-956.
18. Ina K., Kitamura H., Tatsukawa S., Takayama T., Fujikura Y., Shimada T. Transformation of interstitial fibroblasts and tubulointerstitial fibrosis in diabetic nephropathy. Med. Electron. Microsc. 2002, 35, 87-95.
19. Fogarty D. G., Krolewski A. S. Genetic susceptibility and the role of hypertension in diabetic nephropathy. Curr. Opin. Nephrol. Hypertens. 1997, 6, 184-191.
20. Mezzano S. A., Ruiz-Ortega M., Egido J. Angiotensin II and renal fibrosis. Hypertension 2001, 38, 635-638.
21. Weigert C., Brodbeck K., Klopfer K., Haring H. U., Schleicher E. D. Angiotensin II induces human TGF-beta 1 promoter activation: similarity to hyperglycaemia. Diabetologia 2002, 45, 890-898.
22. Lane A., Johnson D. W., Pat B., Winterford C., Endre Z., Wei M., Gobe G. C. Interacting roles of myofibroblasts, apoptosis and fibrogenic growth factors in the pathogenesis of renal tubulo-interstitial fibrosis. Growth Factors 2002, 20, 109-119.
23. Huang C., Kim Y., Caramori M. L., Fish A. J., Rich S. S., Miller M. E., Russell G. B., Mauer M. Cellular basis of diabetic nephropathy: II. The transforming growth factor-beta system and diabetic nephropathy lesions in type 1 diabetes. Diabetes 2002, 51, 3577-3581.
24. Doria A., Onuma T., Warram J. H., Krolewski A. S. Synergistic effect of angiotensin II type I receptor genotype and poor glycaemic control on risk of nephropathy in IDDM. Diabetologia 1997, 40, 1293-1299.
25. Freire M. B., van Dijk D. J., Erman A., Boner G., Warram J. H., Krolewski A. S. DNA polymorphisms in the ACE gene, serum ACE activity and the risk of nephropathy in insulin-dependent diabetes mellitus. Nephrol. Dial. Transplant. 1998, 13, 2553-2558.
26. Rogus J. J., Moczulski D., Freire M. B., Yang Y., Warram J. H., Krolewski A. S. Diabetic nephropathy is associated with AGT polymorphism T235: results of a family-based study. Hypertension 1998, 31, 627-631.
27. Lovati E., Richard A., Frey B. M., Frey F. J., Ferrari P. Genetic polymorphisms of the renin-angiotensin-aldosterone system in end-stage renal disease. Kidney Int. 2001, 60, 46-54.
28. Bachvarov D. R., Landry M., Pelletier I., Chevrette M., Betard C., Houde I., Bergeron J., Lebel M., Marceau F. Characterization of two polymorphic sites in the human kinin B1 receptor gene: altered frequency of an allele in patients with a history of end-stage renal failure. J. Am. Soc. Nephrol. 1998, 9, 598-604.
29. Zychma M. J., Gumprecht J., Zukowska-Szczechowska E., Grzeszczak W. Polymorphisms in the genes encoding for human kinin receptors and the risk of end-stage renal failure: results of transmission/disequilibrium test. The End-Stage Renal Disease Study Group. J. Am. Soc. Nephrol. 1999, 10, 2120-2124.
30. Kato S., Luyckx V. A., Ots M., Lee K.W., Ziai F., Troy J. L., Brenner B. M., MacKenzie H. S. Renin-angiotensin blockade lowers MCP-1 expression in diabetic rats. Kidney Int. 1999, 56, 1037-1048.
31. Morii T., Fujita H., Narita T., Shimotomai T., Fujishima H., Yoshioka N., Imai H., Kakei M., Ito S. Association of monocyte chemoattractant protein-1 with renal tubular damage in diabetic nephropathy. J. Diabetes Complications 2003, 17, 11-15.
32. Nakajima K., Tanaka Y., Nomiyama T., Ogihara T., Piao L., Sakai K., Onuma T., Kawamori R. Chemokine receptor genotype is associated with diabetic nephropathy in Japanese with type 2 diabetes. Diabetes 2002, 51, 238-242.
33. Blakemore A. I., Cox A., Gonzalez A. M., Maskil J. K., Hughes M. E., Wilson R. M., Ward J. D., Duff G. W. Interleukin-1 receptor antagonist allele (IL1 RN*2) associated with nephropathy in diabetes mellitus. Hum. Genet. 1996, 97, 369-374.
34. Loughrey B. V., Maxwell A. P., Fogarty D. G., Middleton D., Harron J. C., Patterson C. C., Darke C., Savage D. A. An interluekin 1B allele, which correlates with a high secretor phenotype, is associated with diabetic nephropathy. Cytokine 1998, 10, 984-988.
35. Ng D. P., Warram J. H., Krolewski A. S. TGF-beta 1 as a genetic susceptibility locus for advanced diabetic nephropathy in type 1 diabetes mellitus: an investigation of multiple known DNA sequence variants. Am. J. Kidney Dis. 2003, 41, 22-28.
36. Rogus J. J., Warram J. H., Krolewski A. S. Genetic studies of late diabetic complications: the overlooked importance of diabetes duration before complication onset. Diabetes 2002, 51, 1655-1662.
37. Culverhouse R., Suarez B. K., Lin J., Reich T. A perspective on epistasis: limits of models displaying no main effect. Am. J. Hum. Genet. 2002, 70, 461-471.
38. Curtis D., North B. V., Sham P. C. A novel method of two-locus linkage analysis applied to a genome scan for late onset Alzheimer's disease. Ann. Hum. Genet. 2001, 65, 473-481.
39. Wilson S. R. Epistasis and its possible effects on transmission disequilibrium tests. Ann. Hum. Genet. 2001, 65, 565-575.
40. Krolewski A. S. Genetics of diabetic nephropathy: evidence for major and minor gene effects. Kidney Int. 1999, 55, 1582-1596.
41. Krolewski A. S., Ng D. P., Canani L. H., Warram J. H. Genetics of diabetic nephropathy: how far are we from finding susceptibility genes? Adv. Nephrol. Necker. Hosp. 2001, 31, 295-315.
42. Eikmans M., Baelde H. J., de Heer E., Bruijn J. A. RNA expression profiling as prognostic tool in renal patients: toward nephrogenomics. Kidney Int. 2002, 62, 1125-1135.